Tag : genomics

Genomics

Streamline Genomics Launches New SeeqVCF VCF Analysis Application

PR Newswire
Streamline Genomics is pleased to announce the launch of SeeqVCF, a lightweight and innovative Variant Call Format (“VCF”) filtering application for users of clinical genomics. VCF...
Genomics

InformedDNA Announces New Exec Leadership to Support Customers

Business Wire
Doug Berman Joins as SVP Channel and Account Management InformedDNA®, the country’s largest applied genomics solutions company, today announced that industry veteran Doug Berman has...
Genomics

Dr. Kimon Angelides Announces Latest Venture, FemTec Health

PR Newswire
Focus Centers Around the BiomeAI™, a platform for personalized data and analysis to create interactive healthcare and individualized products Today, Dr. Kimon Angelides, founder of six...
Genomics

Genomics leader Sequential Skin raise $1.65M in oversubscription

PR Newswire
Sequential Skin Ltd, a UK/Singapore biotech start-up has raised US $1.65M in its oversubscribed seed round – to revolutionise the future of skin health. The round was led...
Genomics

Genomics leader NuProbe enables Mutation Detection on Nanopore

PR Newswire
NuProbe scientists and collaborators recently published a new method for sensitive detection of somatic mutations using Oxford Nanopore sequencing platforms. The method, termed oncogene concatenated...
Genomics

RNA Oncology Company TransCode Therapeutics Awarded Funding

Business Wire
TTX-MC138 targets MicroRNA10b for treatment of metastatic disease; TransCode on track to submit exploratory investigational new drug (eIND) application in Q1 2022 TransCode Therapeutics, Inc....
Genomics

Genomic Medicine Co. Sangamo Therapeutics Reports Q2 Results

Business Wire
Conference Call and Webcast Scheduled for 4:30 p.m. Eastern Time Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported recent business highlights and...
Genomics

Non-invasive Skin Genomics Platform DermTech Reports Q2 2021 Results

Business Wire
DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported unaudited financial results for the quarter...